在二胺胺阳性病例中,请小心错误地归因"modafinil"
Karolina Nowak1,2, Marcin Zawadzki3,4, Paweł Szpot5,2
1Department of Pharmacology, Faculty of Medicine, University of Opole, 48 Oleska Street, 45052, Opole, Poland.
法医毒理学家必须仔细区分基化合物,如二胺和modafinil. 这项研究证实,在二胺胺阳性尸体样本中没有检测到莫达菲尼尔,从而防止了错误归因.
科学领域:
- 法医毒理学 法医毒理学
- 分析化学 分析化学
背景情况:
- 迪芬胺 (抗胰岛素) 和莫达菲尼尔 (清醒剂) 是结构相似的基化合物.
- 由于不同的法律地位和娱乐用途的潜力,精确的区分至关重要.
- 诺尔迪芬胺和莫达菲尼尔的同时使用可能导致错误识别.
研究的目的:
- 调查在二胺胺阳性法医病例中可能存在错误的modafinil归因.
- 开发和验证用于在生物样本中区分这些化合物的分析方法.
主要方法:
- 分析了死后的血液和玻璃体水分样本.
- 用乙酸乙烯在pH值9进行液体液体提取.
- 使用了超高性能液态染色学-并联质谱法 (UHPLC-MS/MS).
主要成果:
- 在二胺胺阳性生物基因表中,莫达菲尼尔被绝对排除在外.
- 全扫描,MRI和产品离子扫描模式证实了莫达菲尼尔的不存在.
结论:
- 在分析基化合物时,需要谨慎的分析程序.
- 通过认证分析标准的验证和代谢物检测可以防止错误识别.
更多相关视频
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Antidepressant Drugs: MAOIs and Other Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
